Aptamers to tissue factor pathway inhibitor and their use as bleeding disorder therapeutics

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 8252913
APP PUB NO 20110098345A1
SERIAL NO

12858369

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The invention relates generally to the field of nucleic acids and more particularly to aptamers that bind to TFPI, which are useful as therapeutics in and diagnostics of bleeding disorders and/or other diseases or disorders in which TFPI has been implicated. In addition, the TFPI aptamers may be used before, during and/or after medical procedures to reduce complications or side effects thereof. The invention further relates to materials and methods for the administration of aptamers that bind to TFPI.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
TAKEDA PHARMACEUTICAL COMPANY LIMITEDOSAKA-SHI OSAKA 541-0045

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Diener, John L Cambridge, US 33 577
Genga, Ryan Somerville, US 3 26
Kurz, Jeffrey C Winchester, US 5 176
McGinness, Kathleen Cambridge, US 14 51
Nelson, Jennifer Boston, US 36 745
Schaub, Robert G Pelham, US 13 159
Waters, Emily Jamaica Plain, US 5 34

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation